Govt job for M.Pharm, M.Sc for Project Assistant at NIPER

National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad is an Institute of National Importance with proclaimed objectives of becoming Centre of Excellence for advanced research in pharmaceutical sciences.

NIPER-Mohali was the first institute established in the year 1998 under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the Govt. of India.

Post : Project Assistant

Applications are invited for a Project Assistant in Lateral Flow Immunoassay Development to work under the supervision of Dr. Vivek Borse for a period of 11 months.

The project involves synthesis, characterization of nanoparticles, bioconjugation and development of lateral flow immunoassay.

Qualifications : B.Sc./ 3 years Diploma in Engineering & Technology
Desirable – B.E., B.Tech, M.Sc., M.Pharm, M.Tech. with practical knowledge, expertise, specialization in Biotechnology, Microbiology, Pharmacy, Bioengineering, Medical Devices, NanoBioTechnology, etc.)

Upper age limit : 50 years

How to Apply
A detailed resume including applicant’s personal details with photograph, educational background, statement of purpose, name of two referees, and copy of all credentials should be submitted by email (vivek.borse@niperhyd.ac.in).

Incomplete application will not be considered.

Last date of receiving applications is 05th October, 2021

Interview date : Interviews will be held as soon as possible thereafter.
Note : Only shortlisted candidates will be intimated to appear for an interview (Online or Offline); No TA/DA will be paid for attending the same

Related Posts

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

New Delhi: The Parliamentary Panel on Health and Family Welfare has recommended various significant regulatory changes in the regulation of medical devices, including decentralisation of approval for all medical devices…

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Parliamentary Panel Recommends Decentralisation Of Approval Of All Medical Devices

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory